Ocrevus®

What is Ocrevus^®?

Ocrevus® (ocrelizumab) is a monoclonal antibody therapy used to treat both relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) in adults. It belongs to a class of anti-CD20 therapies that target and deplete B cells — immune cells involved in the nerve damage caused by MS. For individuals living with MS, Ocrevus® provides a proven and effective treatment option that helps slow disease progression and reduce relapses. Its safety and efficacy have been well established, offering patients greater confidence in long-term disease management.

‍

Why Patients Choose Rocky Mountain Infusion Center to Receive Their Ocrevus^® Infusion:

Clinical Excellence and Neurological Expertise

Our infusion center is led by board-certified neurologists and supported by a team of BSN-prepared and Registered Nurses who specialize in infusion therapy for neurological conditions. We’re committed to providing the highest level of safety, comfort, and personalized attention for each patient.

‍

Lower Costs and Financial Assistance

We manage prior authorization, benefits verification, and financial support programs on your behalf. Our goal is to minimize costs and make high-quality care more accessible.

According to a Cigna report, patients treated at physician-owned infusion centers — like Rocky Mountain MS Clinic’s Infusion Center — tend to have significantly lower out-of-pocket and overall costs compared to those treated in hospital outpatient centers.

‍

Established leader in MS & Neurological care

With 35+ years of experience in multiple sclerosis and neurological treatment, Rocky Mountain MS Clinic has become a trusted resource for patients throughout the region. Our continued commitment to expert care and patient well-being sets us apart in the field of MS treatment.

‍

How does Ocrevus^® work?

In multiple sclerosis (MS), the body’s immune system mistakenly attacks the myelin sheath — the protective covering around nerve fibers in the brain and spinal cord. When this layer is damaged, communication between nerves becomes disrupted, leading to symptoms such as weakness, coordination issues, vision problems, and cognitive changes.

B cells, which carry a marker called CD20, are a key driver of this autoimmune process. Ocrevus® works by binding to the CD20 marker and removing these harmful B cells before they can trigger more inflammation or nerve damage.

While Ocrevus® is not a cure for MS, it helps stabilize the immune system, slow disease progression, and reduce the number of new relapses and lesions, supporting better long-term outcomes.

‍

How much does Ocrevus^® cost?

The cost of Ocrevus® varies based on your insurance plan and individual benefits. At Rocky Mountain MS Clinic, our infusion team is dedicated to making treatment accessible and affordable for every patient.

We partner with most major commercial insurance providers throughout the Rocky Mountain region — including Aetna, Anthem, Blue Cross Blue Shield, Cigna, Humana, and UnitedHealthcare — as well as Medicaid and Medicare.

Our staff handles all prior authorizations and benefits verification for you. We also help guide patients through available copay assistance and foundation programs to reduce out-of-pocket expenses and make care easier to manage.

‍